Accreditation, Certification & Recognition

We are asked this constantly, so here is a direct answer.

What an IASRM fellowship certificate is

IASRM is an international professional and scientific association. Our fellowships, diplomas and masterclasses are structured post-qualification training programmes with a defined curriculum, assessment, hands-on component, mentorship and a research requirement. On completion you receive an IASRM certificate confirming that you completed that training and passed that assessment.

That certificate demonstrates competence and continuing professional development to peers, patients, employers and collaborators. It is the same category of credential as a fellowship from any international professional society.

What it is not

An IASRM certificate is not a statutory medical qualification. It does not add a registrable degree to your name with the National Medical Commission or your state medical council, it does not by itself confer speciality registration, and it does not authorise you to perform any procedure that your existing licence and the law do not already permit.

Nobody should tell you otherwise. If a training provider implies that a private fellowship makes you a registered specialist, treat that as a reason to walk away.

What it does entitle you to

• Structured, assessed training from an international faculty in a defined body of knowledge
• Documented evidence of continuing professional development
• A peer-reviewed publication to your name
• IASRM membership and access to the faculty network
• Standing to teach, present and publish within the IASRM community

Practising within the law

Every IASRM programme teaches the regulatory framework alongside the science, because in regenerative medicine the two cannot be separated. Fellows are taught which interventions are approved standard of care, which may only be delivered inside an approved clinical trial, and which are simply not permitted. Read the regulation guide →

Our position on evidence

IASRM does not teach or endorse the sale of unproven therapies. Where evidence is early, we say so. Where a treatment is investigational, fellows are taught to present it to patients as investigational. Our conferences and guidelines are explicit about the difference between what is established, what is emerging and what is being oversold.